Observation on the efficacy of ningguo tai capsule combined with pazufloxacin in the treatment of urinary tract infections
宁泌泰胶囊联合帕珠沙星治疗泌尿系统感染的疗效观察

摘要

目的 分析泌尿系统感染治疗中宁泌泰胶囊联合帕珠沙星应用对疗效的影响。方法 选取2022年7月至2023年7月本院收治的泌尿系统感染患者平均分为两组，共计100例即分为宁泌泰胶囊联合帕珠沙星的研究组（n=50）和帕珠沙星治疗的参照组（n=50），统计结果比较。结果 研究组治疗后临床效果高于参照组，症状改善和消失时间短于参照组，细菌学变化优于参照组，差异显著有统计学意义（P＜0.05）。结论 在泌尿系统感染治疗中采用帕珠沙星基础上联合使用宁泌泰胶囊能够改善患者的临床症状，促进治疗效果提高。

Abstract

Objective To analyse the effect of the application of Ning Utai capsule combined with Pazufloxacin on the therapeutic efficacy in the treatment of urinary system infection.
Methods: The patients with urinary system infection admitted to our hospital from July 2022 to July 2023 were selected and divided into two groups on average, with a total of 100 cases, i.e., they were divided into the study group of Ning Uitai capsule combined with Pazufloxacin (n=50) and the reference group of Pazufloxacin treatment (n=50), and the statistical results were compared.
Results: The clinical effect of the study group after treatment was higher than that of the reference group, the time of symptom improvement and disappearance was shorter than that of the reference group, and the bacteriological changes were better than that of the reference group, and the difference was statistically significant (P＜0.05).
Conclusion  : The combined use of ningguoitai capsule on the basis of palzhufloxacin in the treatment of urinary system infection can improve the clinical symptoms of patients and promote the therapeutic effect.